Villarante, Bb Girl Ii .

HRN: 27-27-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
06/18/2025
06/25/2025
IV
39mg
Q12
PSNB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: